Douglas Carr Receives Stock Award at Century Therapeutics Inc (IPSC) — SEC Form 4, Jun 10, 2024
SEC Form 4 · No Market Transaction
Stock Award
Compensation grant — no market purchase or sale.
Equity Position
334K sh
317,323 → 334,330
Equity Change
+5.4%
shares held after vs before
Filing Lag
1 business day
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Douglas Carr CIK 0001867173 |
SVP
|
Douglas Carr at Century Therapeutics Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
$28,577
More from this insider at Century Therapeutics Inc
| 2026-09-15 | Sell | -$3,200 | View |
| 2026-09-09 | Sell | -$521 | View |
| 2026-08-05 | Sell | -$544 | View |
| 2026-06-15 | Sell | -$3,692 | View |
| 2026-06-09 | Sell | -$526 | View |
Non-Derivative Securities Transactions
| Title | Date | Type | Shares | Price | Net Total | Post-Txn | Ownership |
|---|---|---|---|---|---|---|---|
| Common StockF1 | 2024-06-07 | A - Award/Grant | 17,007 A | $0.00 | — | 334,330 | Direct |
Footnotes (1)
- F1
- Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Century Therapeutics, Inc.'s (the "Company's") common stock. The RSUs vest 100% on June 7, 2025, subject the Reporting Person's continued service through such vesting date. The RSUs will be settled on each applicable vesting date in shares of the Company's common stock. Show more
Related filings at Century Therapeutics Inc
Institutional Holders
13F holders · Jun 30, 2026
100
institutional managers reporting a position
Largest by reported value
- Ra Capital Management, L.P. $43.5M
- Tcg Crossover Management, Llc $43.4M
- Versant Venture Management, Llc $29.8M
5%+ Holders · 13D/G
6 filers
Other insiders at Century Therapeutics Inc
GET /v1/forms/4/0001062993-24-012312
API docs
View Original SEC Filing